Make comprehensive risk assessment
part of your routine practice
Your patient may be eligible for two or more geneTypes.
Review the eligibility criteria for each below.
Patient Eligibility
- Men may be eligible for as many as 7 tests
- Women may be eligible for as many as 8 tests
- *dependent on patient personal medical history and self-identified race/ethnicity; melanoma, pancreatic cancer and atrial fibrillation are not yet available
Proactive Healthcare
A wellness visit general health check is an opportunity to consider your patient’s ongoing health and motivate them to maintain healthy lifestyles and compliant screening practices.
Let geneType be a tool to enable preventative care discussions with your patient.
Engage your patient’s understanding of their personal risk of disease by communicating:
- Value in screening compliance (based on current screening guidelines)
- Available supplemental screening options
- Available risk reducing medication options
- Available lifestyle modifications to reduce disease-risk (e.g. smoking cessation, improved nutrition, reducing alcohol consumption, increased physical activity)
Incorporate geneType into your patient’s next wellness visit
While many risk assessments focus on family history and heritable genetic markers, geneType Multi-Risk Test goes beyond this by incorporating clinical, familial and genetic factors that affect disease risk.
Your patient’s risk assessment can then be used to develop a personalized, preventative health plan that includes screening, risk-reducing medication and/or lifestyle interventions.
Actionable Clinical Insights
GeneType Reports reflect the tests that you requested on your patient’s clinical questionnaire. Reports are structured to make the results easy to interpret and communicate to your patients.
Reports include:
- Snapshot of your patient’s absolute risk scores
- Interpretation of what their risk scores mean in the context of current guidelines
- Polygenic risk score indicating your patient’s “baseline” risk for disease
- Information about modifiable risk factors
- The types of disease-specific screening and risk-reduction interventions available to your patient
Contact us for more information.
GeneType testing is simple
Step 1
Register as a provider; our team will provide clinical education and other resources as needed.
GeneType will send kits to your clinic to have on hand.
Step 2
Discuss geneType with your patient.
Would geneType help her qualify for additional risk reduction strategies?
Step 3
Complete the Test Requisition form, collect a sample from the patient in the saliva tube provided and return both to geneType.
You will have the option to use a paper requisition, or a secure, HIPAA-compliant portal to complete the ordering process.
Step 4
Leave the rest to us.
GeneType will notify you when your patient’s results are ready.
You will have the option to request a consult with a genetic counsellor, whether to review your patient’s results and/or to follow-up with your patient, as needed.
Patient out-of-pocket costs
geneType is a self-pay test. Patient is billed directly.
FSA/HSA may be used to pay for the test.
The geneType suite can be purchased for $349.
Take the first step towards personalized, preventative healthcare
Learn more about each individual risk assessment included within the Multi-Suite.
Breast Cancer
GeneType provides lifetime and 5-year risk scores for breast cancer
Colorectal Cancer
GeneType provides lifetime and 10-year risk scores for colorectal cancer
Ovarian Cancer
GeneType provides lifetime and 10-year risk scores for ovarian cancer
Coronary Artery Disease
GeneType provides a 10-year risk score for coronary artery disease
Type 2 Diabetes
GeneType provides an 8-year risk score for type 2 diabetes
Prostate Cancer
GeneType provides lifetime and 5-year risk scores for prostate cancer
Pancreatic Cancer
In the developmental pipeline
Melanoma
In the developmental pipeline
Atrial Fibrillation
In the developmental pipeline
Do you have questions?
We have answers.
If your question is not shown here, contact us directly.
Is this test reimbursed by insurance?
Ready to get started with geneType?
The first step is to trial geneType at your practice.
Blog posts
GeneType Multi-Risk assessments tailored to your needs
It’s not always easy to know what questions to ask your Doctor. Here are some breast cancer risk questions…
Breast Cancer risk – Starting the conversation
It’s not always easy to know what questions to ask your Doctor. Here are some breast cancer risk questions…
Proactive steps for breast cancer risk reduction
Breast awareness is important whether you are 35 or 75. When you understand your risk, you can be a better advocate for yourself…
Keep up-to-date with our latest advances
Sign up to our newsletter to stay informed about our latest advances and how these could support your practice.
Accredited For Compliance With NPAAC Standards And ISO 15189
CLIA Number 99D2023356
